TIDMGSK

RNS Number : 2392U

GSK PLC

29 July 2022

Issued: 29 July 2022, London UK

GSK Board change

GSK plc (LSE/NYSE: GSK) has today announced that Dr Laurie Glimcher has advised the Company of her intention to retire from the Board on 13 October 2022 after over 5 years as a Non-Executive Director and designated Scientific and Medical Expert.

GSK expects to announce further Non-Executive Director appointments in due course.

Victoria Whyte

Company Secretary

29 July 2022

Notes

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com/company

 
GSK enquiries 
Media:               Tim Foley        +44 (0) 20 8047      (London) 
                                       5502 
                     Kathleen Quinn   +1 202 603 5003      (Washington DC) 
 
Investor Relations:  Nick Stone       +44 (0) 7717 618834  (London) 
                     James Dodwell    +44 (0) 20 8047      (London) 
                                       2406 
                     Mick Readey      +44 (0) 7990 339653  (London) 
                     Josh Williams    +44 (0) 7385 415719  (London) 
                     Jeff McLaughlin  +1 215 751 7002      (Philadelphia)

Cautionary statement regarding forward-looking statements

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the Company's Annual Report on Form 20-F for 2021, GSK's Q2 Results for 2022 and any impacts of the COVID-19 pandemic.

Registered in England & Wales:

No. 3888792

Registered Office:

980 Great West Road

Brentford, Middlesex

TW8 9GS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOASEUSAUEESEFW

(END) Dow Jones Newswires

July 29, 2022 05:00 ET (09:00 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Gsk Charts.